Insulin Detemir Reduces Hypoglycemic Risk at Comparable HbAfc Values Compared to NPH Insulin in Patients with Type 1 Diabetes

被引：0
|
作者：
Hermansen, Kjeld
Heller, Simon
Andersen, Marc
Russell-Jones, David L.
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A529 / A530
页数：2
相关论文
共 50 条
  • [41] NPH increases the risk of insulin resistance in type 1 diabetes
    Silva, L. V.
    Franca, Liana C.
    Silvano, Paulo Z.
    Barth, Robson
    dos Santos, Gustavo J.
    DIABETOLOGIA, 2024, 67 : S254 - S255
  • [42] Cerebral glucose metabolism in human type 1 diabetes is increased after treatment with insulin detemir compared to NPH insulin: possible explanation for differences in weight?
    van Golen, L. W.
    Huisman, M. C.
    Ijzerman, R. G.
    Hoetjes, N. J.
    Schwarte, L. A.
    Schober, P.
    Hoogma, R. P.
    Drent, M. L.
    Lammertsma, A. A.
    Diamant, M.
    DIABETOLOGIA, 2011, 54 : S287 - S288
  • [43] Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia
    Erik Johansen, Odd
    Johan Vanberg, Pal
    Kvarv Kilhovd, Bente
    Palmstrom Jorgensen, Anders
    VASCULAR HEALTH AND RISK MANAGEMENT, 2009, 5 : 121 - 128
  • [44] Therapy class conversion in patients with type 2 diabetes: Economic evaluation of insulin detemir and NPH
    Valentine, W. J.
    Cobden, D.
    Palmer, A. J.
    Wagner, S.
    Roze, S.
    VALUE IN HEALTH, 2006, 9 (06) : A230 - A230
  • [45] A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes
    Home, PD
    Rosskamp, R
    Forjanic-Klapproth, J
    Dressler, A
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (06) : 545 - 553
  • [46] Long-term clinical outcomes of insulin detemir versus NPH for type 1 diabetes patients in Spain
    Kotchie, R.
    Aagren, M.
    Nielsen, S.
    Valentine, W. J.
    Goodall, G.
    VALUE IN HEALTH, 2007, 10 (06) : A273 - A273
  • [47] Treatment with insulin detemir or NPH insulin in children aged 2-5 yr with type 1 diabetes mellitus
    Thalange, Nandu
    Bereket, Abdullah
    Larsen, Jens
    Hiort, Line Conradsen
    Peterkova, Valentina
    PEDIATRIC DIABETES, 2011, 12 (07) : 632 - 641
  • [48] Perinatal outcomes in pregnancy: a randomised trial comparing insulin detemir with NPH insulin in 310 subjects with type 1 diabetes
    Hod, M.
    McCance, D. R.
    Ivanisevic, M.
    Garcia, S.
    Jovanovic, L.
    Mathiesen, E. R.
    Damm, P.
    DIABETOLOGIA, 2011, 54 : S487 - S487
  • [49] A comparison of the basal insulin analog, insulin detemir (NN304), with NPH insulin in the management of type 1 diabetic patients
    Hermansen, K
    Madsbad, S
    Perrild, H
    Kristensen, A
    Axelsen, M
    DIABETES, 2000, 49 : A110 - A111
  • [50] Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes
    K. Hermansen
    P. Fontaine
    K. K. Kukolja
    V. Peterkova
    G. Leth
    M.-A. Gall
    Diabetologia, 2004, 47 : 622 - 629
12345